Edward A. Ogunro
Direktor/Vorstandsmitglied bei MPN Research Foundation
Aktive Positionen von Edward A. Ogunro
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MPN Research Foundation | Direktor/Vorstandsmitglied | - | - |
DelNova, Inc.
DelNova, Inc. Pharmaceuticals: MajorHealth Technology DelNova, Inc. engages in the development of therapeutics. Its lead clinical candidate is ReViVox?, a patent-pending product for the rescue of complications caused by off-target muscle paralysis following aesthetic and medical neurotoxin therapies. The company was founded by Mary Gardner in 2016 and is headquartered in Highland, IL. | Direktor/Vorstandsmitglied | - | - |
Prenosis, Inc.
Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | Direktor/Vorstandsmitglied | 05.10.2022 | - |
Karriereverlauf von Edward A. Ogunro
Ehemalige bekannte Positionen von Edward A. Ogunro
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LUMINEX CORPORATION | Direktor/Vorstandsmitglied | 22.05.2009 | 14.07.2021 |
Independent Dir/Board Member | 29.11.2011 | 14.07.2021 | |
Applied NeuroSolutions, Inc.
Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Applied NeuroSolutions, Inc. is a development stage biopharmaceutical company that engages in the research and development of a diagnostic tests to detect and novel therapeutics to treat Alzheimer's disease in humans. It researches and develops pharmaceuticals with an emphasis on products for infectious, inflammatory and other diseases. The company was founded on March 14, 1992 and is headquartered in Vernon Hills, IL. | Direktor/Vorstandsmitglied | 30.10.2008 | 19.01.2011 |
HOSPIRA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.04.2004 | 01.12.2007 |
Feinberg School of Medicine | Corporate Officer/Principal | 01.01.1977 | 01.01.1982 |
Abbott Hospital Products | General Counsel | - | - |
ABBOTT LABORATORIES | Technik-/Wissenschafts-/F&E-Leiter | 01.06.1980 | - |
General Counsel | 01.06.1980 | - |
Ausbildung von Edward A. Ogunro
The University of Reading | Undergraduate Degree |
University of London | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Vereinigtes Königreich | 3 |
Operativ
Director/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 2 |
General Counsel | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 4 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ABBOTT LABORATORIES | Health Technology |
Private Unternehmen | 7 |
---|---|
Applied NeuroSolutions, Inc.
Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Applied NeuroSolutions, Inc. is a development stage biopharmaceutical company that engages in the research and development of a diagnostic tests to detect and novel therapeutics to treat Alzheimer's disease in humans. It researches and develops pharmaceuticals with an emphasis on products for infectious, inflammatory and other diseases. The company was founded on March 14, 1992 and is headquartered in Vernon Hills, IL. | Health Technology |
Luminex Corp.
Luminex Corp. Medical SpecialtiesHealth Technology Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The firm's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The company was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX. | Health Technology |
Hospira, Inc.
Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
MPN Research Foundation | |
Abbott Hospital Products | |
DelNova, Inc.
DelNova, Inc. Pharmaceuticals: MajorHealth Technology DelNova, Inc. engages in the development of therapeutics. Its lead clinical candidate is ReViVox?, a patent-pending product for the rescue of complications caused by off-target muscle paralysis following aesthetic and medical neurotoxin therapies. The company was founded by Mary Gardner in 2016 and is headquartered in Highland, IL. | Health Technology |
Prenosis, Inc.
Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | Technology Services |
- Börse
- Insiders
- Edward A. Ogunro
- Erfahrung